...
首页> 外文期刊>Surgery >Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin.
【24h】

Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin.

机译:伴有肝外疾病切除术对大肠源性肝转移患者的预后价值。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Operative resection is the treatment of choice for colorectal liver metastasis. In the present study, we investigated the prognostic factors after hepatic resection, focusing on the concomitant resection of extrahepatic metastases. METHOD: A retrospective cohort study was performed in 187 consecutive patients who had undergone initial hepatic resections for colorectal metastases using the Cox proportional hazards model. RESULTS: The overall survival rates at 3, 5, and 10 years were 49%, 30%, and 22%, respectively. Hilar lymph node involvement (HLN), localized peritoneal seeding (P), and distant organ metastasis (M) were resected in addition to the liver metastases in 9, 13, and 21 patients, respectively. The P and M factors were related univariately to an unfavorable patient prognosis, but the HLN factor was not. In a multivariate regression analysis, the hazard ratios of these three factors of interest were 1.58 (HLN; 95% confidence interval 0.64-2.52, median survival 48 months), 2.12 (P; 1.38-2.85, 18 months), and 3.07 (M; 2.45-3.68, 19 months), respectively. CONCLUSION: Aggressive operative resection for colorectal liver metastases yielded an acceptable long-term outcome. The presence of distant organ metastasis seems to be a contraindication for operative intervention and/or resection; although the number of patients enrolled in the present study was small, resection of localized peritoneal seeding or hilar lymph node involvement, in addition to the resection of the liver metastases, may benefit patient survival.
机译:背景:手术切除是结直肠肝转移的首选治疗方法。在本研究中,我们调查了肝切除术后的预后因素,重点是肝外转移灶的同时切除。方法:采用Cox比例风险模型,对187例因大肠转移而进行了初次肝切除的连续肝切除患者进行了回顾性队列研究。结果:3年,5年和10年的总生存率分别为49%,30%和22%。除肝转移外,分别切除9、13和21例患者的肝门淋巴结受累(HLN),局部腹膜播种(P)和远处器官转移(M)。 P和M因子与患者预后不良单相关,而HLN因子与患者的预后无关。在多元回归分析中,这三个关注因素的危险比分别为1.58(HLN; 95%置信区间0.64-2.52,中位生存期48个月),2.12(P; 1.38-2.85,18个月)和3.07(M ; 2.45-3.68,19个月)。结论:大肠肝转移的积极手术切除取得了可接受的长期结果。远处器官转移的出现似乎是手术干预和/或切除的禁忌证;尽管参加本研究的患者人数很少,但切除肝转移的局部腹膜播种或肺门淋巴结受累切除术可能会有利于患者的生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号